The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Prostacyclin Market Research Report 2024
Synopsis
Prostaglandins are autocank derived from arachidonic acid. They both sustain homeostatic functions and mediate pathogenic mechanisms, including the inflammatory response. Prostaglandins control several processes in the body, especially as it relates to the healing process. When tissue is damaged or infected, this group of hormones will create the reactions that cause pain, fever and inflammation, which sparks the healing process. Prostaglandins also stimulate the formation of a blood clot and the contraction of the blood vessel wall when body is bleeding. Once blood clots are no longer needed and the injury begins to heal, another prostaglandin will stimulate the changes that allow the clots to dissipate and the blood vessel wall to relax.
The global Prostacyclin market was valued at US$ 2367 million in 2023 and is anticipated to reach US$ 3847.4 million by 2030, witnessing a CAGR of 7.1% during the forecast period 2024-2030.
United Therapeutics monopolizes the global Prostacyclin market, holding a share about 70%.
North America is the largest market, with a share about 80%, followed by Europe and Japan, have a share about 15 percent.
In terms of product, Beraprost Sodium is the largest segment, with a share over 50%. And in terms of application, the largest application is For Oral, followed by For Injection, For Inhalation.
This report aims to provide a comprehensive presentation of the global market for Prostacyclin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prostacyclin.
Report Scope
The Prostacyclin market size, estimations, and forecasts are provided in terms of sales volume (K Unit) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Prostacyclin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Prostacyclin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
United Therapeutics
Actelion (J & J)
GSK
Teva
Toray
Tide Pharma
Bayer AG
Segment by Type
Epoprostenol Sodium
Treprostinil
Iloprost
Beraprost Sodium
Segment by Application
For Injection
For Oral
For Inhalation
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Prostacyclin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Prostacyclin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Prostaglandins are autocank derived from arachidonic acid. They both sustain homeostatic functions and mediate pathogenic mechanisms, including the inflammatory response. Prostaglandins control several processes in the body, especially as it relates to the healing process. When tissue is damaged or infected, this group of hormones will create the reactions that cause pain, fever and inflammation, which sparks the healing process. Prostaglandins also stimulate the formation of a blood clot and the contraction of the blood vessel wall when body is bleeding. Once blood clots are no longer needed and the injury begins to heal, another prostaglandin will stimulate the changes that allow the clots to dissipate and the blood vessel wall to relax.
The global Prostacyclin market was valued at US$ 2367 million in 2023 and is anticipated to reach US$ 3847.4 million by 2030, witnessing a CAGR of 7.1% during the forecast period 2024-2030.
United Therapeutics monopolizes the global Prostacyclin market, holding a share about 70%.
North America is the largest market, with a share about 80%, followed by Europe and Japan, have a share about 15 percent.
In terms of product, Beraprost Sodium is the largest segment, with a share over 50%. And in terms of application, the largest application is For Oral, followed by For Injection, For Inhalation.
This report aims to provide a comprehensive presentation of the global market for Prostacyclin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prostacyclin.
Report Scope
The Prostacyclin market size, estimations, and forecasts are provided in terms of sales volume (K Unit) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Prostacyclin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Prostacyclin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
United Therapeutics
Actelion (J & J)
GSK
Teva
Toray
Tide Pharma
Bayer AG
Segment by Type
Epoprostenol Sodium
Treprostinil
Iloprost
Beraprost Sodium
Segment by Application
For Injection
For Oral
For Inhalation
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Prostacyclin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Prostacyclin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Prostacyclin Market Overview
1.1 Product Overview and Scope of Prostacyclin
1.2 Prostacyclin Segment by Type
1.2.1 Global Prostacyclin Market Value Comparison by Type (2024-2030)
1.2.2 Epoprostenol Sodium
1.2.3 Treprostinil
1.2.4 Iloprost
1.2.5 Beraprost Sodium
1.3 Prostacyclin Segment by Application
1.3.1 Global Prostacyclin Market Value by Application: (2024-2030)
1.3.2 For Injection
1.3.3 For Oral
1.3.4 For Inhalation
1.4 Global Prostacyclin Market Size Estimates and Forecasts
1.4.1 Global Prostacyclin Revenue 2019-2030
1.4.2 Global Prostacyclin Sales 2019-2030
1.4.3 Global Prostacyclin Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Prostacyclin Market Competition by Manufacturers
2.1 Global Prostacyclin Sales Market Share by Manufacturers (2019-2024)
2.2 Global Prostacyclin Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Prostacyclin Average Price by Manufacturers (2019-2024)
2.4 Global Prostacyclin Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Prostacyclin, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Prostacyclin, Product Type & Application
2.7 Prostacyclin Market Competitive Situation and Trends
2.7.1 Prostacyclin Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Prostacyclin Players Market Share by Revenue
2.7.3 Global Prostacyclin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Prostacyclin Retrospective Market Scenario by Region
3.1 Global Prostacyclin Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Prostacyclin Global Prostacyclin Sales by Region: 2019-2030
3.2.1 Global Prostacyclin Sales by Region: 2019-2024
3.2.2 Global Prostacyclin Sales by Region: 2025-2030
3.3 Global Prostacyclin Global Prostacyclin Revenue by Region: 2019-2030
3.3.1 Global Prostacyclin Revenue by Region: 2019-2024
3.3.2 Global Prostacyclin Revenue by Region: 2025-2030
3.4 North America Prostacyclin Market Facts & Figures by Country
3.4.1 North America Prostacyclin Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Prostacyclin Sales by Country (2019-2030)
3.4.3 North America Prostacyclin Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Prostacyclin Market Facts & Figures by Country
3.5.1 Europe Prostacyclin Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Prostacyclin Sales by Country (2019-2030)
3.5.3 Europe Prostacyclin Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Prostacyclin Market Facts & Figures by Country
3.6.1 Asia Pacific Prostacyclin Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Prostacyclin Sales by Country (2019-2030)
3.6.3 Asia Pacific Prostacyclin Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Prostacyclin Market Facts & Figures by Country
3.7.1 Latin America Prostacyclin Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Prostacyclin Sales by Country (2019-2030)
3.7.3 Latin America Prostacyclin Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Prostacyclin Market Facts & Figures by Country
3.8.1 Middle East and Africa Prostacyclin Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Prostacyclin Sales by Country (2019-2030)
3.8.3 Middle East and Africa Prostacyclin Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Prostacyclin Sales by Type (2019-2030)
4.1.1 Global Prostacyclin Sales by Type (2019-2024)
4.1.2 Global Prostacyclin Sales by Type (2025-2030)
4.1.3 Global Prostacyclin Sales Market Share by Type (2019-2030)
4.2 Global Prostacyclin Revenue by Type (2019-2030)
4.2.1 Global Prostacyclin Revenue by Type (2019-2024)
4.2.2 Global Prostacyclin Revenue by Type (2025-2030)
4.2.3 Global Prostacyclin Revenue Market Share by Type (2019-2030)
4.3 Global Prostacyclin Price by Type (2019-2030)
5 Segment by Application
5.1 Global Prostacyclin Sales by Application (2019-2030)
5.1.1 Global Prostacyclin Sales by Application (2019-2024)
5.1.2 Global Prostacyclin Sales by Application (2025-2030)
5.1.3 Global Prostacyclin Sales Market Share by Application (2019-2030)
5.2 Global Prostacyclin Revenue by Application (2019-2030)
5.2.1 Global Prostacyclin Revenue by Application (2019-2024)
5.2.2 Global Prostacyclin Revenue by Application (2025-2030)
5.2.3 Global Prostacyclin Revenue Market Share by Application (2019-2030)
5.3 Global Prostacyclin Price by Application (2019-2030)
6 Key Companies Profiled
6.1 United Therapeutics
6.1.1 United Therapeutics Corporation Information
6.1.2 United Therapeutics Description and Business Overview
6.1.3 United Therapeutics Prostacyclin Sales, Revenue and Gross Margin (2019-2024)
6.1.4 United Therapeutics Prostacyclin Product Portfolio
6.1.5 United Therapeutics Recent Developments/Updates
6.2 Actelion (J & J)
6.2.1 Actelion (J & J) Corporation Information
6.2.2 Actelion (J & J) Description and Business Overview
6.2.3 Actelion (J & J) Prostacyclin Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Actelion (J & J) Prostacyclin Product Portfolio
6.2.5 Actelion (J & J) Recent Developments/Updates
6.3 GSK
6.3.1 GSK Corporation Information
6.3.2 GSK Description and Business Overview
6.3.3 GSK Prostacyclin Sales, Revenue and Gross Margin (2019-2024)
6.3.4 GSK Prostacyclin Product Portfolio
6.3.5 GSK Recent Developments/Updates
6.4 Teva
6.4.1 Teva Corporation Information
6.4.2 Teva Description and Business Overview
6.4.3 Teva Prostacyclin Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Teva Prostacyclin Product Portfolio
6.4.5 Teva Recent Developments/Updates
6.5 Toray
6.5.1 Toray Corporation Information
6.5.2 Toray Description and Business Overview
6.5.3 Toray Prostacyclin Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Toray Prostacyclin Product Portfolio
6.5.5 Toray Recent Developments/Updates
6.6 Tide Pharma
6.6.1 Tide Pharma Corporation Information
6.6.2 Tide Pharma Description and Business Overview
6.6.3 Tide Pharma Prostacyclin Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Tide Pharma Prostacyclin Product Portfolio
6.6.5 Tide Pharma Recent Developments/Updates
6.7 Bayer AG
6.6.1 Bayer AG Corporation Information
6.6.2 Bayer AG Description and Business Overview
6.6.3 Bayer AG Prostacyclin Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Bayer AG Prostacyclin Product Portfolio
6.7.5 Bayer AG Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Prostacyclin Industry Chain Analysis
7.2 Prostacyclin Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Prostacyclin Production Mode & Process
7.4 Prostacyclin Sales and Marketing
7.4.1 Prostacyclin Sales Channels
7.4.2 Prostacyclin Distributors
7.5 Prostacyclin Customers
8 Prostacyclin Market Dynamics
8.1 Prostacyclin Industry Trends
8.2 Prostacyclin Market Drivers
8.3 Prostacyclin Market Challenges
8.4 Prostacyclin Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
